N-Nitroso Finasteride EP Impurity C
| ISP CAT No | |
|---|---|
| Mol.F. | |
| Mol.Wt. | |
| Inv. Status |
Disclaimer
The product information provided on this website by ISPStandards is based on the best available understanding at the time of publication. Customers are responsible for verifying the accuracy of this information before making a purchase. ISPStandards may update product details as new information or specifications become available, without prior notice.
- Product Overview
- Description
- Technical Data
Description
Chemical Name: (4aR,4bS,6aS,7S,9aS,9bS)-N-(Tert-butyl)-4a,6a-dimethyl-N-nitroso-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10-dodecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
Shipping Temperature:
Ambient
HSN Code:
38229010
Country of Origin: India
Smiles: C[C@]12C(NC(C=C2)=O)=CC[C@]3([H])[C@]1([H])CC[C@@]4(C)[C@@]3([H])CC[C@]4([H])C(N(C(C)(C)C)N=O)=O
Additional Information
N-Nitroso Finasteride EP Impurity C is chemically (4aR,4bS,6aS,7S,9aS,9bS)-N-(Tert-butyl)-4a,6a-dimethyl-N-nitroso-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10-dodecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide.
N-Nitroso Finasteride EP Impurity C is supplied with detailed characterization data compliant with regulatory guideline. N-Nitroso Finasteride EP Impurity C can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Finasteride.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use.
Mechanism-Based Inhibition of Human Steroid 5R-Reductase by Finasteride: Enzyme-Catalyzed Formation of NADP-Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor
